MPM BioImpact’s ADC Therapeutics ADCT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q4 | – | Sell |
-334,384
| Closed | -$1.61M | – | 34 |
|
|
2022
Q3 | $1.61M | Hold |
334,384
| – | – | 0.38% | 35 |
|
|
2022
Q2 | $2.66M | Hold |
334,384
| – | – | 0.74% | 29 |
|
|
2022
Q1 | $4.91M | Sell |
334,384
-3,012
| -0.9% | -$44.2K | 1.32% | 21 |
|
|
2021
Q4 | $6.82M | Sell |
337,396
-7,123
| -2% | -$144K | 1.24% | 21 |
|
|
2021
Q3 | $9.36M | Buy |
344,519
+126,492
| +58% | +$3.44M | 1.45% | 16 |
|
|
2021
Q2 | $5.31M | Hold |
218,027
| – | – | 0.87% | 14 |
|
|
2021
Q1 | $5.32M | Sell |
218,027
-321,621
| -60% | -$7.85M | 0.67% | 13 |
|
|
2020
Q4 | $17.3M | Hold |
539,648
| – | – | 3.03% | 10 |
|
|
2020
Q3 | $17.8M | Hold |
539,648
| – | – | 4.29% | 8 |
|
|
2020
Q2 | $25.3M | Buy |
+539,648
| New | +$25.3M | 6.72% | 7 |
|